| Metric | შპს ფარმა სესი+ | შპს ემ ფარმა | შპს SIAPHARM | შპს საქართველოს ფარმაცევტული კომპანია |
|---|---|---|---|---|
| Growth | ||||
| Revenue | ₾2.7m₾0 | ₾4.6m₾4.5m | ₾3.9m₾4.5m | ₾4.3m₾2.5m |
| Revenue growth | — | 2.2% | -15.0% | 72.0% |
| Profitability | ||||
| EBITDA | ₾9k₾0 | -₾111k | ||
| ₾379k₾12k |
| ₾421k₾351k |
| EBITDA margin | 0.3% | -2.4%-5.9% | 9.8%0.3% | 9.9%14.2% |
| Net profit | ₾9k₾0 | -₾637k-₾680k | ₾157k-₾63k | ₾232k₾378k |
| Net margin | 0.3% | -13.8%-15.1% | 4.1%-1.4% | 5.5%15.3% |
| Balance sheet | ||||
| Total assets | ₾555k₾487k | ₾3.1m₾2.9m | ₾1.7m₾1.8m | ₾1.2m₾475k |
| Total equity | ₾155k₾114k | ₾1.0m₾1.2m | ₾368k₾212k | ₾703k₾471k |
| ROE | 5.9%0.0% | -60.9%-58.1% | 42.6%-30.0% | 33.0%80.3% |